Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $323.89 | 8 | 97.4% |
| Education | $8.54 | 3 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc. | $168.28 | 4 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $125.75 | 2 | $0 (2023) |
| Vifor Pharma, Inc. | $15.26 | 1 | $0 (2022) |
| Relypsa, Inc. | $14.60 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $8.54 | 3 | Travere Therapeutics, Inc. ($8.54) |
| 2023 | $108.67 | 1 | AstraZeneca Pharmaceuticals LP ($108.67) |
| 2022 | $156.38 | 3 | Bayer HealthCare Pharmaceuticals Inc. ($141.12) |
| 2021 | $27.16 | 2 | Bayer HealthCare Pharmaceuticals Inc. ($27.16) |
| 2020 | $31.68 | 2 | AstraZeneca Pharmaceuticals LP ($17.08) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $2.38 | General |
| 09/30/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 09/26/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 03/02/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $108.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/20/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $122.84 | General |
| Category: Cardio-renal | ||||||
| 04/14/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Cardio-renal | ||||||
| 01/20/2022 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Hyperkalemia | ||||||
| 12/09/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $11.34 | General |
| Category: Cardio-renal | ||||||
| 10/09/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Cardio-renal | ||||||
| 11/03/2020 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Hyperkalemia | ||||||
| 09/24/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 520 | 944 | $402,815 | $95,092 |
| 2022 | 7 | 418 | 828 | $283,786 | $75,991 |
| 2021 | 6 | 335 | 592 | $187,597 | $51,112 |
| 2020 | 4 | 94 | 142 | $43,558 | $12,590 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 134 | 245 | $74,411 | $21,172 | 28.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 72 | 159 | $47,528 | $14,083 | 29.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 33 | 74 | $69,664 | $11,718 | 16.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 83 | 193 | $40,032 | $11,219 | 28.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 85 | 85 | $39,553 | $9,998 | 25.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 62 | 71 | $41,279 | $8,998 | 21.8% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 12 | 39 | $40,297 | $8,375 | 20.8% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2023 | 12 | 50 | $39,735 | $7,471 | 18.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 15 | $6,145 | $1,367 | 22.3% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 12 | 13 | $4,170 | $692.64 | 16.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 115 | 369 | $76,538 | $19,861 | 25.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 99 | 201 | $49,173 | $18,332 | 37.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 68 | 78 | $45,349 | $11,740 | 25.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 89 | 89 | $34,118 | $10,442 | 30.6% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 11 | 38 | $39,264 | $8,671 | 22.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 22 | 36 | $33,890 | $5,995 | 17.7% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 14 | 17 | $5,453 | $949.06 | 17.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 104 | 274 | $56,833 | $14,852 | 26.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 63 | 131 | $31,272 | $12,137 | 38.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 88 | 88 | $33,466 | $10,726 | 32.1% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 28 | 38 | $35,773 | $6,192 | 17.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 37 | 41 | $23,837 | $6,091 | 25.6% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 15 | 20 | $6,415 | $1,115 | 17.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 31 | 75 | $15,557 | $4,197 | 27.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 23 | 24 | $13,954 | $3,749 | 26.9% |
About Dr. Ann Herron, MD
Dr. Ann Herron, MD is a Nephrology healthcare provider based in Murfreesboro, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2015. The National Provider Identifier (NPI) number assigned to this provider is 1336533710.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ann Herron, MD has received a total of $332.43 in payments from pharmaceutical and medical device companies, with $8.54 received in 2024. These payments were reported across 11 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($323.89).
As a Medicare-enrolled provider, Herron has provided services to 1,367 Medicare beneficiaries, totaling 2,506 services with total Medicare billing of $234,785. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Murfreesboro, TN
- Active Since 03/24/2015
- Last Updated 09/12/2024
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1336533710
Products in Payments
- Kerendia (Drug) $168.28
- FARXIGA (Drug) $108.67
- Veltassa (Drug) $29.86
- LOKELMA (Drug) $17.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Murfreesboro
Christie Green, Md, MD
Nephrology — Payments: $10,433
Jyotheen Karam, M.d, M.D
Nephrology — Payments: $3,594
Dr. Benjamin Studdard, M.d, M.D
Nephrology — Payments: $3,089
Christin Giordano Mcauliffe, Md, MD
Nephrology — Payments: $512.03
Dr. Taylor Chaney, Do, DO
Nephrology